FAM90A25P

Across TCGA pan-cancer cohorts, FAM90A25P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FAM90A25P data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher FAM90A25P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM90A25P expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.

LGG, BLCA, and THYM are the cancer types where FAM90A25P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.673	0.798	<.001	43	view →
BLCA	OS	Quartile	II,III,IV	0.746	0.548	.003	36	view →
THYM	OS	Quartile	All	0.855	1.000	.010	28	view →
ACC	DFS	Tertile	All	0.385	0.796	.002	28	view →
KIRC	DFS	Tertile	II,III,IV	0.410	0.604	.007	27	view →
PAAD	OS	Quartile	All	0.633	0.239	.002	26	view →
MESO	DFS	Median	III,IV	0.665	0.236	.007	24	view →
ESCA	DFS	Median	II,III,IV	0.415	0.564	.019	18	view →
PRAD	OS	Median	All	0.977	1.000	.013	14	view →
LUSC	OS	Quartile	III,IV	0.563	0.760	.035	14	view →
KIRP	DFS	Tertile	II,III,IV	0.858	0.491	.018	10	view →
BRCA	OS	Tertile	IV	0.765	0.175	.008	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

FAM90A25P–LGG (DFS)

Open the LGG breakdown →